Physics and Regulation in One Team
Drug developers and hospitals need an isotope partner that understands both the physics and the regulations. NEVNUCLAB brings that expertise, together with a breakthrough technology.
Next-generation medical isotopes, without a nuclear reactor. NEVNUCLAB’s technology opens a new way to make the isotopes that radioligand therapy and theranostics depend on. Copper-67 (Cu-67) comes first, then actinium-225 (Ac-225).
When a new isotope therapy is ready for patients, the isotope should be ready too.
Founded in 2023, NEVNUCLAB brings together decades of experience in nuclear physics, the nuclear industry, and nuclear and healthcare regulation, gained at national laboratories, research institutes, and nuclear companies. Our team works in the United States and Europe.
Medical isotope supply is fragile, and the isotopes behind new cancer therapies are hard to find. Our mission is to give nuclear medicine a secure source of next-generation medical isotopes.
We exist to turn scientific potential into clinical reality.
At NEVNUCLAB, we are driven by:
Our in-house legal team ensures full compliance with complex international regulations governing nuclear materials, medical isotope distribution, and cross-border logistics. With deep experience in radiation protection, licensing, nonproliferation, and nuclear liability, we navigate the legal landscape so our partners, from research labs to pharma companies, can operate with confidence and speed.
Drug developers and hospitals need an isotope partner that understands both the physics and the regulations. NEVNUCLAB brings that expertise, together with a breakthrough technology.
Whether you work at a pharmaceutical company, a research institution, a hospital, or a government agency, we would like to hear from you. Our team is available to discuss partnerships, research collaborations, and regulatory pathways. Reach out today and tell us which isotopes matter to your work.
Bringing next-generation medical isotopes to patients takes more than one company. If you are a researcher, healthcare leader, investor, or policymaker working to advance patient care, we invite you to collaborate with NEVNUCLAB. Together, we can close critical supply gaps in nuclear medicine.
All Rights Reserved | NEVNUCLAB